<?xml version="1.0" encoding="UTF-8"?>
<p>In 2017, the Africa region contributed 30% of the 30 high TB/HIV and multidrug resistant TB (MDR-TB) countries worldwide [
 <xref rid="pone.0231637.ref006" ref-type="bibr">6</xref>]. Five of these countries were from Southern Africa, a region described as the epicentre of HIV and TB infection, with high migration and extreme poverty [
 <xref rid="pone.0231637.ref006" ref-type="bibr">6</xref>–
 <xref rid="pone.0231637.ref008" ref-type="bibr">8</xref>] Zimbabwe is one of the five high TB, HIV and MDR-TB burden countries from Southern Africa with a TB/HIV co-infection rate of 68% and TB incidence of 242/100,000 in 2017 [
 <xref rid="pone.0231637.ref006" ref-type="bibr">6</xref>] Despite a falling national TB incidence, the country failed to meet the Millennium Development Goal (MDG) targets of halving the TB incidence by 50% in 2017. In line with international best practice, the Zimbabwe National TB Control Program’s (NTP)’s guidelines recommends ambulatory TB care for both sputum smear positive and smear negative TB patients [
 <xref rid="pone.0231637.ref009" ref-type="bibr">9</xref>].
</p>
